| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d21cbff64022f95c237c0bd3ec8656ca |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y108-01008 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-44 |
| filingDate |
2004-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97393e0afbe9721eb6addc3495b3114e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e65e0a198878689681449b74b7417d4 |
| publicationDate |
2005-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2005208037-A1 |
| titleOfInvention |
Thioredoxin increases redox-cycling of anticancer agents thereby sensitizes cancer cells to apoptosis |
| abstract |
The present invention provides for treatment of cancer by enhancing the effectiveness of anticancer agents. The present invention therefore provides methods of increasing the apoptotic potential of anticancer drugs by increasing the expression of the cellular redox protein thioredoxin or thioredoxin-like molecules and thereby sensitizing the cancer to the anticancer agent. The present invention also provides methods of ameliorating negative side-effects of an anticancer therapy comprising a thioredoxin or a thioredoxin-like molecule and an anticancer therapy. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2242360-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2242360-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009102808-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9803230-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10640808-B2 |
| priorityDate |
2003-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |